Fifteen preovulatory hirsute woman were studied before and at the completionof one cycle (21 days) of an oral contraceptive that contained norethindrone (2 mg) and mestranol (0.1 mg; N + M). A 3-day protocol included a diurnal study, followed by overnight dexamethasone suppression and ACTH stimulation. Plasma A4-androstenedione (A), testosterone (T), and dehydroepiandrosterone sulfate (DHEAS) and plasma cortisol (F) were meDHEAS was reduced 28%, and F was increased 176% with therapy. A exhibiteda diurnal rhythm synchronouswith F across all of the time periods, but T and DHEAS did not. ACTH dependency of A was determined by measuring the magnitude of changein A between the timeof the F peak and the F nadir in the diurnal study. In the diurnal study, both themean concentration of A as wellas the net change in plasma A concentration from the time of theF peak to the F nadir correlated significantly with the mean DHEAS concentration during N+ M treatment. The responsiveness of A and F to 0.5 U ACTH iv was determined afterdexamethasone (mg)had beengiven the night before. On treatment, dexamethasone-suppressed mean F values wer higher and mean A levels were lower. The incremental increase above the dexamethasone-suppressedlevels was significantly decreased for A,but was significantly increased fo F during N + M treatment. The responsiveness of A and F to 0.5 U ACTH iv was determined after dexamethasone (1 mg) had been given the night before. On treatment, dexamethasone-suppressed mean F values were higher and mean A levels were lower. The incremental increase above the dexamethasone-suppressed levels was significantly decreased for A, but was significantly increased for F during N + M treatment. The response of A to ACTH correlated significantly with the mean concentration of DHEAS during but not before treatment. The significant reduction in plasma A and T by N + M noted in this study confirms the usefulness of this agent in reducing androgen levels in hirsute women. The data ofthis study document that N + M reducesadrenal androgen activity as evidenced by 1 a reduction of the magnitude of the diurnalchange in A synchronous with F, 2) a reductionof the A response to exogenous ACTH, and 3) a reduction in the circulating concentration of DHEAS. DHEAS correlated significantly with the mean and the difference in the peak to nadiaconcentration in the diurnal study and with the A response to ACTH during N + M. This suggests that this relatively simple assay can serve as an indicator of the magnitud ofadrenal androgen secretion in hirsute females.
No takes yet. Share an insight, caveat, or question.
Wild et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: